Aligos Therapeutics Inc. (ALGS): Price and Financial Metrics
ALGS Price/Volume Stats
| Current price | $39.84 | 52-week high | $41.64 |
| Prev. close | $38.35 | 52-week low | $6.76 |
| Day low | $36.35 | Volume | 469,100 |
| Day high | $41.64 | Avg. volume | 110,714 |
| 50-day MA | $18.61 | Dividend yield | N/A |
| 200-day MA | $16.23 | Market Cap | 142.95M |
ALGS Stock Price Chart Interactive Chart >
Aligos Therapeutics Inc. (ALGS) Company Bio
Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.
ALGS Price Returns
| 1-mo | 101.31% |
| 3-mo | 335.89% |
| 6-mo | 271.47% |
| 1-year | 127.66% |
| 3-year | -86.12% |
| 5-year | N/A |
| YTD | 140.00% |
| 2023 | -30.32% |
| 2022 | -91.97% |
| 2021 | -57.07% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...